Cardinal Health settled allegations that it violated Controlled Substances Act reporting provisions relating to its handling of certain controlled substances regulated by the Drug Enforcement Administration (DEA). The government alleged that Cardinal Health failed to report to DEA suspicious orders of hydrocodone it distributed to pharmacies that filled illegitimate prescriptions originating from “rogue” Internet pharmacy Web sites. Under the agreement between the company and U.S. Attorney’s Offices in Florida, Texas, Washington State, New Jersey, Georgia, California, and Colorado, Cardinal Health agreed to pay $34 million in civil penalties.